Mary Ann Liebert, Inc., publishers and Genetic Engineering & Biotechnology News (GEN) have announced the launch of Re:GEN Open, the new multidisciplinary open access journal for scientifically rigorous research in the life and medical sciences.
Re:GEN Open combines the dynamic, global media presence of GEN with the scientific peer-reviewed publishing expertise of Mary Ann Liebert, Inc. to deliver an unprecedented publishing experience: best-in-class author services, rapid and fair peer-review, and international exposure across the leading media platforms in the industry.
Re:GEN Open will publish fully open access original research, reviews, and frontmatter across all areas of the life sciences, including drug discovery, OMICS, genome editing, bio-processing, translational medicine, cancer research, infectious diseases, and artificial intelligence. Authors who publish in Re:GEN Open will benefit from a dynamic, end-to-end publishing experience that ensures authoritative, credible peer-review and unprecedented exposure for their published work across the Mary Ann Liebert, Inc. and GEN global audiences.
Click here to read the original press release.
